HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Acute kidney injury after cardiac arrest.

AbstractINTRODUCTION:
The aim of this study was to evaluate the incidence and determinants of AKI in a large cohort of cardiac arrest patients.
METHODS:
We reviewed all patients admitted, for at least 48 hours, to our Dept. of Intensive Care after CA between January 2008 and October 2012. AKI was defined as oligo-anuria (daily urine output <0.5 ml/kg/h) and/or an increase in serum creatinine (≥0.3 mg/dl from admission value within 48 hours or a 1.5 time from baseline level). Demographics, comorbidities, CA details, and ICU interventions were recorded. Neurological outcome was assessed at 3 months using the Cerebral Performance Category scale (CPC 1-2 = favorable outcome; 3-5 = poor outcome).
RESULTS:
A total of 199 patients were included, 85 (43%) of whom developed AKI during the ICU stay. Independent predictors of AKI development were older age, chronic renal disease, higher dose of epinephrine, in-hospital CA, presence of shock during the ICU stay, a low creatinine clearance (CrCl) on admission and a high cumulative fluid balance at 48 hours. Patients with AKI had higher hospital mortality (55/85 vs. 57/114, p = 0.04), but AKI was not an independent predictor of poor 3-month neurological outcome.
CONCLUSIONS:
AKI occurred in more than 40% of patients after CA. These patients had more severe hemodynamic impairment and needed more aggressive ICU therapy; however the development of AKI did not influence neurological recovery.
AuthorsOmar Tujjar, Giulia Mineo, Antonio Dell'Anna, Belen Poyatos-Robles, Katia Donadello, Sabino Scolletta, Jean-Louis Vincent, Fabio Silvio Taccone
JournalCritical care (London, England) (Crit Care) Vol. 19 Pg. 169 (Apr 17 2015) ISSN: 1466-609X [Electronic] England
PMID25887258 (Publication Type: Journal Article)
Topics
  • Acute Kidney Injury (epidemiology, etiology, therapy)
  • Anuria (diagnosis)
  • Heart Arrest (complications, epidemiology, mortality, therapy)
  • Hospital Mortality
  • Humans
  • Intensive Care Units
  • Length of Stay
  • Oliguria (diagnosis)
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: